KATP blocker. Exhibits in vitro tissue selectivity for pancreatic β-cell-type KATP channels over cardiovascular KATP channels; displays high affinity for SUR1/Kir6.2 channels. Hypoglycemic agent; stimulates insulin secretion from pancreatic β-cells by increasing cytosolic Ca2+ concentration.